Market Tracker

02/24 12:20pm ET

Catalyst Biosciences Inc (NASDAQ:CBIO)

5.94
Delayed Data
As of 12:01pm ET
 -0.35 / -5.56%
Today’s Change
5.81
Today|||52-Week Range
50.70
-39.09%
Year-to-Date
How to Dig Deep for Value in These Exuberant Markets
Feb 23 / TheStreet.com - Paid Partner Content
Value Investors Have to Go Deeper
Feb 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close6.29
Today’s open6.16
Day’s range5.81 - 6.45
Volume38,615
Average volume (3 months)51,367
Market cap$5.0M
Dividend yield9.75%
Data as of 12:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+50.96%
Earnings growth (this year)+54.50%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)+536.36%
P/E ratio0.1
Price/Sales7.92
Price/Book0.15

Competitors

 Today’s
change
Today’s
% change
--VANC Pharmaceuticals...+0.01+3.70%
SSKNSTRATA Skin Sciences...-0.01-2.05%
OPXAOpexa Therapeutics I...-0.03-2.88%
BSPMBiostar Pharmaceutic...-0.01-0.35%
Data as of 12:03pm ET, 02/24/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$5.63
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.8M
Net profit margin-843.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer &
Head-Investor Relations
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts